Courtesy of Duke Children's Hospital

The regulatory environment surrounding childhood cancer drug development is changing, and increased attention to such development within industry is becoming a higher priority. COG can directly assist industry partners in this global landscape. From formulating development plans that can support pediatric exclusivity, to establishing a feasible Pediatric Investigation Plan, Children’s Oncology Group expertise can assist.

The expertise within COG is widely recognized by regulatory agencies. Thus independent assessments from our experts can help refine initial proposals into studies that provide key data in a clinical trial development plan designed for pediatric patients. Understanding the current cancer treatment landscape is essential when developing such plans, as feasibility of study proposals are central to future success.

The COG has successfully collaborated with numerous industry partners, from small biotech to global pharmaceutical companies. To learn more, email COG Industry Sponsored Trials Program (IST) at This email address is being protected from spambots. You need JavaScript enabled to view it.  or call (626) 241-1512. The Children’s Oncology Group – The world’s childhood cancer experts.

 

National Clinical Trials Network Logo NCI-COG Pediatric MATCH Logo

 

Project Every Child Logo

 

Step Up More Funding for Childhood Cancer LogoCOG Foundation Logo   amazon smile donate